The year in cardiovascular medicine 2021: dyslipidaemia

Lale Tokgozoglu1, Carl Orringer2, Henry N Ginsberg3

  • 1Department of Cardiology, Hacettepe University Faculty of Medicine, Sıhhiye, 06100 Ankara, Turkey.

European Heart Journal
|January 2, 2022
PubMed

Insights

Recent advances in clinical lipidology focus on lowering LDL cholesterol and triglycerides. New therapies targeting novel pathways and lipoprotein(a) are emerging, promising personalized lipid-lowering treatments.

Area of Science:

  • Clinical lipidology
  • Cardiovascular research
  • Pharmacology

Background:

  • Lipid management is crucial for cardiovascular health.
  • Genetic studies have identified novel therapeutic targets.
  • Triglyceride-rich lipoproteins and Lp(a) are increasingly recognized as atherogenic.

Purpose of the Study:

  • To review recent advancements in clinical lipidology.
  • To highlight emerging therapies for lipid lowering.
  • To discuss the potential for personalized lipid management.

Main Methods:

  • Review of recent clinical lipidology literature.
  • Analysis of genetic studies identifying novel pathways.
  • Evaluation of emerging therapeutic agents for lipid disorders.

Main Results:

  • Exploration of diverse mechanisms to lower LDL cholesterol.
  • Renewed focus on triglyceride-rich lipoproteins and Lp(a) with new treatments.
  • Development of targeted therapeutics showing significant Lp(a) reduction.

Conclusions:

  • The field of lipidology has expanded with new therapeutic options.
  • Personalized lipid-lowering strategies will be enhanced by upcoming outcome data.
  • Novel agents offer potential for more effective cardiovascular risk reduction.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
62
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
295
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
938
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
376
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60